Advancing & Refining Potency Assays for CAR-T Cell Therapies
Time: 11:00 am
day: Conference Day Two
Details:
- Focusing on vector potency and the debate between interferon gamma and cytotoxicity as industry standards
- Achieving precision and accuracy, particularly in the context of CAR-T drug products
- Examining the forced degraded materials and evaluating its impact using various potency methods to understand product functionality
